Platform|API|Archive|Contact
Humanexa SignalsPharmaceutical Intelligence
Subscribe
Signals
Regulatory
  • FDA
  • EMA
  • MHRA
  • PMDA
  • Health Canada
Clinical
  • Phase I
  • Phase II
  • Phase III
  • Readouts
  • Enrollment Signals
Competitive
  • Pipeline Tracking
  • Company Moves
  • Asset Intelligence
  • Landscape Reports
Markets
  • Pricing
  • Access
  • Commercial
  • Launch Tracking
M&A Watch
  • Licensing
  • Acquisitions
  • Partnerships
  • Capital Raises
StrategyCatalystsPricing
Humanexa Signals

Data-driven pharmaceutical intelligence for biotech investors, pharma operators, consultants, and intelligence teams.

Powered by Humanexa

Categories

  • Regulatory
  • Clinical
  • Competitive
  • Markets
  • M&A Watch
  • Strategy
  • Catalyst Tracker

Company

  • Pricing
  • Partner with us
  • Subscribe
  • Contact
  • Privacy

Subscribe to Humanexa Signals

Weekly intelligence for pharma decision-makers.

No paywall. No spam. Unsubscribe anytime.

© 2026 Humanexa Signals. All rights reserved.

Intelligence powered by the Humanexa engine.

Therapeutic Area

Surgical Intervention

Therapeutic area intelligence for Surgical Intervention with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.

Signals
4
Catalysts
0
Companies
0

Companies

No related entities indexed yet.

Assets

Cardiology →
Feasibility →

Recent signals(4)

ClinicalAugust 1, 2026

Study on Bariatric Embolization Before Sleeve Gastrectomy in Super Obese Patients

The study evaluates the safety and effectiveness of bariatric embolization prior to sleeve gastrectomy in patients with severe obesity.

ClinicalJuly 19, 2026

Feasibility Study on IRE System for Adenotonsillar Hypertrophy in Children

A multi-center feasibility study is underway to assess the safety and efficacy of the IRE System for treating adenotonsillar hypertrophy in children.

ClinicalJune 29, 2026

Study on Bariatric Endoscopic Antral Myotomy (BEAM) for Obesity Underway

A pilot study is evaluating the safety and efficacy of Bariatric Endoscopic Antral Myotomy (BEAM) for weight loss.

ClinicalJune 2, 2026

Trial on Pulmonary Artery Catheters in Cardiac Surgery Aims to Compare Recovery Outcomes

This clinical trial will evaluate the impact of avoiding pulmonary artery catheters on recovery outcomes in cardiac surgery patients.

Upcoming catalysts

No catalysts indexed for this entity yet.

Indications

Obesity →

Newsletter

Get signals before the market moves

Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.

No paywall. No spam. Unsubscribe anytime.